Cite
Circulating and Intracellular miRNAs as Prognostic and Predictive Factors in HER2-Positive Early Breast Cancer Treated with Neoadjuvant Chemotherapy: A Review of the Literature.
MLA
Isca, Chrystel, et al. “Circulating and Intracellular MiRNAs as Prognostic and Predictive Factors in HER2-Positive Early Breast Cancer Treated with Neoadjuvant Chemotherapy: A Review of the Literature.” Cancers, vol. 13, no. 19, Oct. 2021, p. 4894. EBSCOhost, https://doi.org/10.3390/cancers13194894.
APA
Isca, C., Piacentini, F., Mastrolia, I., Masciale, V., Caggia, F., Toss, A., Piombino, C., Moscetti, L., Barbolini, M., Maur, M., Dominici, M., & Omarini, C. (2021). Circulating and Intracellular miRNAs as Prognostic and Predictive Factors in HER2-Positive Early Breast Cancer Treated with Neoadjuvant Chemotherapy: A Review of the Literature. Cancers, 13(19), 4894. https://doi.org/10.3390/cancers13194894
Chicago
Isca, Chrystel, Federico Piacentini, Ilenia Mastrolia, Valentina Masciale, Federica Caggia, Angela Toss, Claudia Piombino, et al. 2021. “Circulating and Intracellular MiRNAs as Prognostic and Predictive Factors in HER2-Positive Early Breast Cancer Treated with Neoadjuvant Chemotherapy: A Review of the Literature.” Cancers 13 (19): 4894. doi:10.3390/cancers13194894.